These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Familial lecithin:cholesterol acyltransferase deficiency. Biochemistry of the cornea. Winder AF; Garner A; Sheraidah GA; Barry P J Lipid Res; 1985 Mar; 26(3):283-7. PubMed ID: 3989388 [TBL] [Abstract][Full Text] [Related]
5. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study. Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681 [TBL] [Abstract][Full Text] [Related]
7. The circulation of fluid at the limbus (flow and diffusion at the limbus). McCulley JP Eye (Lond); 1989; 3 ( Pt 2)():114-20. PubMed ID: 2695345 [TBL] [Abstract][Full Text] [Related]
8. Studies on the pathogenesis of corneal arcus formation II. Immunofluorescent studies on lipid deposition in the eye of the lipid-fed rabbit. Walton KW; Dunkerley DJ J Pathol; 1974 Dec; 114(4):217-29. PubMed ID: 4141731 [No Abstract] [Full Text] [Related]
9. [Update on dyslipoproteinemias and their role in changes in the statoacoustic apparatus]. Pallestrini EA; Borasi F Ann Laringol Otol Rinol Faringol; 1978; 76(3):239-76. PubMed ID: 233339 [No Abstract] [Full Text] [Related]
10. Pathogenesis and management of lipoprotein disorders. Schaefer EJ; Levy RI N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163 [No Abstract] [Full Text] [Related]
11. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
12. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. Segal P; Insull W; Chambless LE; Stinnett S; LaRosa JC; Weissfeld L; Halfon S; Kwiterovitch PO; Little JA Circulation; 1986 Jan; 73(1 Pt 2):I108-18. PubMed ID: 3940677 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of plasma and biliary lipids in hyperlipoproteinaemia. Leijd B Acta Med Scand Suppl; 1979; 635():1-32. PubMed ID: 295570 [No Abstract] [Full Text] [Related]
14. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558 [TBL] [Abstract][Full Text] [Related]
15. Clinical disorders of lipoprotein metabolism. Brewer HB; Gregg RE; Hoeg JM; Law S Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557 [No Abstract] [Full Text] [Related]
16. [Lipoprotein metabolism in the blood plasma and liver in alimentary dyslipoproteinemias in an experiment]. Liapkov BG Vopr Pitan; 1985; (5):32-7. PubMed ID: 4082518 [TBL] [Abstract][Full Text] [Related]